Dimerix

Dimerix Cash Flow per Share

The Operating Cash Flow per Share of Dimerix (DXB.AX) as of Oct 11, 2026 is -0.09 AUD. In the previous year, Operating Cash Flow per Share was 0.07 AUD — a change of -232.64% (lower).

Cash Flow per Share

-0.09AUD

YoY

-232.64%

Last updated:

Operating Cash Flow per Share of Dimerix is 2026 -0.09 AUD. Operating Cash Flow per Share of Dimerix was 2025 0.07 AUD. It decreases by -232.64% lower compared to the previous year.

The Dimerix Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2019
-0.02 AUD
Jan 1, 2020
-0.02 AUD
Jan 1, 2021
-0.02 AUD
Jan 1, 2022
-0.04 AUD
Jan 1, 2023
-0.03 AUD
Jan 1, 2024
-0.01 AUD
Jan 1, 2025
0.07 AUD
Jan 1, 2026
-0.09 AUD
The Dimerix Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.09AUD-232.64%
0.07AUD-615.31%
-0.01AUD-59.76%
-0.03AUD-23.74%
-0.04AUD+73.66%
-0.02AUD+1.01%
-0.02AUD+40.28%
-0.02AUD-17.87%
-0.02AUD+0.09%
-0.02AUD+9.71%
-0.02AUD+118.11%
-0.01AUD-42.93%
-0.01AUD—
Access this data via the Eulerpool API
Get Free API Key

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Operating Cash Flow per Share of Dimerix is -0.09 AUD in 2026.

Operating Cash Flow per Share of Dimerix changed from 0.07 AUD to -0.09 AUD, representing a -232.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Dimerix since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Dimerix

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Dimerix